Owner Beijing Wantai Biological Pharmacy Enterprise Co., Ltd

Inventors Gu, Ying; Xia, Ningshao; He, Zhiqiang; Li, Shaowei; Zhang, Jun; Ge, Shengxiang

Agent Davies Collison Cave

Pub. Number AU-B-2002349727

PCT Number PCT/CN02/00797

PCT Pub. Number WO2003/040187

Priority 01134643.4 08.11.01 CN

Filing date 8 November 2002

Wipo publication date 19 May 2003

Acceptance publication date 16 October 2008

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 31/20 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/08 (2006.01) Peptides having more than 20 amino acids

C07K 16/08 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

G01N 33/576 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for hepatitis

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

G01N 33/00 (2006.01) Investigating or analysing materials by specific methods not covered by groups